Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00221351 · ClinicalTrials.gov registry record · NA
C-reactive Protein (CRP)-Guided Management Algorithm for Adults With Acute Cough
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 139
- Enrollment target
NCT00221351 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 139 participants.
The verdict
NCT00221351, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 139 participants
- Enrollment target
Study Summary
We aim to evaluate the impact of a CRP-guided management algorithm for adults with acute cough illness. More specifically, we will examine both process of care and clinical outcomes: 1. Processes of care (i.e., chest x-rays ordered, antibiotic treatment, length-of-time in the ED). We hypothesize that CRP-guided management will be associated with a decrease in the antibiotic prescription for acute cough illness from 50 percent to 30 percent. 2. Clinical outcomes (i.e., duration of illness, any return visit, return visit with a diagnosis of pneumonia, hospitalization, subsequent antibiotic use, satisfaction with care). We hypothesize that there will be no difference in the proportion of patients feeling back to normal within 2 weeks of their ED visit for acute cough illness (about 60 percent, 95% confidence interval=50 to 70 percent).
Interventions
- PROCEDURE CRP point of care testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2005-10 |
| Est. Completion | 2006-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00221351
The ClinicalTrials.gov registry entry for NCT00221351 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CRP point of care testing is the first listed.
NCT00221351 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00221351 about?
NCT00221351 is a clinical study titled "C-reactive Protein (CRP)-Guided Management Algorithm for Adults With Acute Cough". We aim to evaluate the impact of a CRP-guided management algorithm for adults with acute cough illness. More specifically, we will examine both process of care and clinical outcomes: 1. Processes of care (i.e., chest x-rays ordered, antibiotic treatment, length-of-time in the ED). We hypothesize th...
What is the current status of trial NCT00221351?
This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2005-10. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00221351?
The interventions under investigation include: CRP point of care testing (PROCEDURE).
Who is sponsoring clinical trial NCT00221351?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.